A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This is a regulatory-required non-interventional pharmacovigilance study exploring the safety
profile of ziprasidone HCL monohydrate 20mg, 40mg, 60mg, 80mg in the real world patient
population, thus, safety (and/or efficacy) signals will be checked at every visit during the
contracted study period until the maximum study end date, per the protocol, of April 2010.
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.